# Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer

> **NCT00810797** · PHASE2 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 36 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** exemestane
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** quality-of-life assessment
- **OTHER:** immunohistochemistry staining method

## Key facts

- **NCT ID:** NCT00810797
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-02
- **Primary completion:** 2019-06-26
- **Final completion:** 2019-06-26
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00810797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00810797, "Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00810797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*